Copyright Registrations and the Importance of Being Accurate (Earnest May Not Be Enough)

by Rex A. Donnelly Fall is in the air, and that means the October 2021 opening session of the Supreme Court is right around the corner.  Once again, the Court has an Intellectual Property case on its docket — specifically, a copyright matter.  Unicolors, Inc. v. H&M Hennes & Mauritz, LP (Supreme Court Docket #20-915) […]

Read more

James Matthew Gould to Present at the American Conference Institute’s Hatch-Waxman and BPCIA Passport to Proficiency Series

Philadelphia, PA | September 2021 – RatnerPrestia’s James Matthew Gould will be the lead-off speaker for intellectual property as part of the FDA/IP interplay portion of ACI’s upcoming Hatch-Waxman and BPCIA Passport to Proficiency Series, a three-week program designed to provide new lawyers and executives in the life sciences industry with a solid foundation for […]

Read more

RatnerPrestia’s Robert A. Esposito , PhD, J.D., Becomes Adjunct Professor at Temple University College of Engineering

Philadelphia, PA | September 2021 – RatnerPrestia is pleased to announce that Robert A. Esposito, PhD, J.D., will be an adjunct professor at the Temple University College of Engineering during the fall semester. He will be teaching a senior level electrical engineering course entitled “Embedded Systems”. The course and its corresponding laboratory focuses on system-on-chip […]

Read more

The Often Unrecognized Dangers of U.S. Export Control Violations and the Benefits of Self-Reporting

by Brett J. Rosen A global software company recently agreed to pay combined penalties of more than $8 million as part of a global resolution with the U.S. Department of Justice (DOJ) resulting from its export control violations.  Beginning in 2010 and continuing through 2017, the software company, without an export license, either exported or […]

Read more

James Matthew Gould to Present at the American Conference Institute’s 19th Advanced Summit on Life Sciences Patents

Philadelphia, PA | July 2021 – RatnerPrestia’s James Matthew Gould will be presenting an interactive case study in the pharmaceutical patent litigation space on July 22, 2021, at the American Conference Institute‘s upcoming 19th Advanced Summit on Life Sciences Patents. His topic will focus on allegations of patent infringement when generic companies carve out patented indications […]

Read more

Supreme Court Rules APJs Are Inferior Officers, Grants Director Additional Oversight Review

by Christopher H. Blaszkowski & Shayne D. Rasay In United States v. Arthrex, Inc., 594 U.S. ___ (2021), the Supreme Court determined that the authority exercised by Administrative Patent Judges (APJs) in rendering inter partes review (IPR) decisions as members of the Patent Trial and Appeal Board (PTAB) violates the Appointments Clause of the Constitution. […]

Read more

The “Moral” Waiver of IP Protection For COVID Vaccines: Why The US Proposal Creates More Problems Than It Solves

By Jonathan H. Spadt & Andrew J. Koopman This month, the Biden administration announced its support for a waiver of intellectual property (IP) protections relating to the production of COVID-19 vaccines.  Few would take issue with the purported goal of such a waiver—speeding access to these life-saving vaccines in nations still deep in the throes […]

Read more

Tillis, Michel, and Iancu Amicus Brief in Favor of Affirming Judge Gilstrap’s Anti-Interference Injunction

by Jonathan H. Spadt & Christopher H. Blaszkowski On April 9, 2021, Senator Thom Tillis (R-NC), the Honorable Paul Michel, and the Honorable Andrei Iancu submitted a joint amicus brief in Samsung’s appeal of Judge Gilstrap’s anti-interference injunction. Without taking a position on the exact nature of the injunction required, the brief argued in favor […]

Read more

Avoid IP Pitfalls When Dissolving and Winding Up Your Business

by Glenn E.J. Murphy Both Forbes and the New York Times report that about twenty percent of new businesses formed in 2021 will fail within their first year of existence, about thirty percent within two years, about fifty percent within five years, and about seventy percent will fail by their tenth year.  But even those […]

Read more

RatnerPrestia’s CEO Jonathan H. Spadt to Moderate Global Series Meeting: Trade Challenges: Managing Today’s New Dynamics on Commerce, Technology Distribution, and Data Policy

Washington, D.C. | April 2021 – RP CEO Jonathan H. Spadt, will be moderating a set of important and timely exchanges on April 29 as a part of the on-going Global Series meetings of the Federal Circuit Bar Association.  The virtual meeting, scheduled for 11:00 a.m. EDT – 12:30 p.m. EDT, will open with a […]

Read more

Previous Entries

Please enter your e-mail address to receive a link to the webinar video.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Please enter your e-mail address to receive a link to the webinar video.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.